EventPilot Web App

Enter Note Done

Session

Clinical
Clinical Decision Making in Pulmonary Hypertension: Navigating the Evolving Landscape

Schedule

Notes

Clinical Science Zone 2‚ Moderated Digital Poster 22

HF.MDP.28

Set Timezone

Timezone

View Map

Generic 'disconnected' Message

Description: This session highlights the dynamic nature of clinical decision-making in pulmonary hypertension amid evolving guidelines, therapies, and diagnostic tools. Experts will present case-based discussions and evidence-driven strategies to personalize treatment, manage comorbidities, and adapt to new data shaping risk stratification and therapeutic pathways. This is not a CE accredited session.

Moderator(s):
Stephen Y Chan (UNIVERSITY OF PITTSBURGH)
Willard Nathan Applefeld (Duke)

Communities

Navigation

Program Selection

Session Type

Presentations

Willard Nathan Applefeld

Stephen Y Chan

Moderated Digital Poster Silent Listening

Optimal hemodynamic status and prognostic predictors in patients with right ventricular dysfunction: the RIGHT study

Q&A

Characterization and Prognostic Implications of Pulmonary Hypertension on Right Heart Catheterization Among Patients with Myeloproliferative Neoplasms

Q&A

Differential Pathophysiological Mechanism of Exercise Intolerance in Non-Obese Versus Obese Patients with Heart Failure and Preserved Ejection Fraction

Q&A

Mechanical Augmentation of the Failing Heart Results in Improved Intraventricular Synchrony Without Blood Contact

Q&A

Influence of Cardiovascular Magnetic Resonance Imaging Phenotype and Variant Type on Ventricular Arrhythmia Risk in RBM20-Related Cardiomyopathy

Q&A

Pulmonary Hypertension Associated with Rheumatic Heart Disease Presents a Major Unmet Disease Burden in Sub-Saharan Africa

Q&A

Left ventricular peak early diastolic strain rate detected by two-dimensional speckle tracking echocardiography and prognosis in pre-capillary pulmonary hypertension

Q&A

Time Trends and Demographic Disparities in Pulmonary Hypertension-Related Mortality in the United States, 2003–2023

Q&A

Contemporary Use Of Parenteral Prostacyclin Administration In Pulmonary Artery Hypertension

Q&A

Q&A